Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.8.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash flows from operating activities    
Net income (loss) $ (1,228) $ 7,242
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 3,731 2,745
Equity-based compensation 1,845 2,569
Equity method investments 9,052 (1,118)
Non-cash gain on securitization (7,256) (4,223)
Gain on sale of receivables and investments 0 300
Changes in receivables held-for-sale 3,243 0
Changes in accounts payable and accrued expenses (866) (742)
Other (3,174) (1,529)
Net cash provided by (used in) operating activities 5,347 5,244
Cash flows from investing activities    
Equity method investments 0 (97,656)
Equity method distributions received 23,387 13,847
Purchases of receivables (3,441) (35,505)
Principal collections from receivables 10,275 32,222
Proceeds from sales of receivables 0 12,084
Purchases of real estate 0 (106,854)
Purchases of investments (3,826) (10,106)
Principal collections from investments 744 48
Funding of escrow accounts (9,655) 0
Withdrawal from escrow accounts 8,647 0
Other (297) (29,905)
Net cash provided by (used in) investing activities 25,834 (221,825)
Cash flows from financing activities    
Proceeds from credit facilities 0 235,612
Principal payments on credit facilities 0 (112,228)
Proceeds from issuance of non-recourse debt 30,952 114,424
Principal payments on non-recourse debt (28,787) (15,803)
Payments on deferred funding obligations (16,993) (30,369)
Net proceeds of common stock issuances 0 67,840
Payments of dividends and distributions (17,606) (15,850)
Other (367) (3,379)
Net cash provided by (used in) financing activities (32,801) 240,247
Increase (decrease) in cash, cash equivalents, and restricted cash (1,620) 23,666
Cash, cash equivalents, and restricted cash at beginning of period 118,177 59,144
Cash, cash equivalents, and restricted cash at end of period 116,557 82,810
Interest paid 17,427 11,526
Non-cash changes in deferred funding obligations (financing activity) 0 33,822
Non-cash changes in receivables and investments (investing activity) 0 (33,822)
Non-cash changes in residual assets (investing activity) $ (7,761) $ (4,223)